Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections.
about
Microbicides: topical prevention against HIVMicrobicides and HIV: A Review and an update.In vitro and in vivo evaluation of two carrageenan-based formulations to prevent HPV acquisition.Bridging the gap between preclinical and clinical microbicide trials: blind evaluation of candidate gels in murine models of efficacy and safety.Semen enhances HIV infectivity and impairs the antiviral efficacy of microbicides.Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infectionAbolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex-forming oligonucleotideUC781 microbicide gel retains anti-HIV activity in cervicovaginal lavage fluids collected following twice-daily vaginal applicationEfficacy of HIV antiviral polyanionic carbosilane dendrimer G2-S16 in the presence of semenTheaflavin-3,3'-digallate and lactic acid combinations reduce herpes simplex virus infectivity.Microbicides: still a long road to successCurrent and future microbicide approaches aimed at preventing HIV infection in women.From the laboratory to clinical trials and back again: lessons learned from HIV prevention trials.Secreted mucosal antimicrobials in the female reproductive tract that are important to consider for HIV prevention.A dual-chamber model of the female genital tract to evaluate epithelial toxicity of candidate anti-HIV microbicides.Putative functions of tissue kallikrein-related peptidases in vaginal fluid.Activation of protease-activated receptor-2 disrupts vaginal epithelial barrier function.
P2860
Q26999403-DC51FA97-6EAB-4444-8202-C6207AF52A25Q30424145-0A07BFD4-50BE-4996-B65D-B0CEFB9838ACQ33978803-273727FB-B099-44DA-871C-6B07014CB214Q34078011-F021314A-4415-43A6-9685-F93039463313Q35213456-CB0D2508-6DB6-4C62-AF19-8D0F841AE988Q36018953-F27A0B14-4DA3-4C6E-B3AD-8F3185F8EF81Q36083853-18A7E16B-B2E6-4742-A55A-F94D79CA5653Q36086344-6ED60E3F-30F7-4D43-933C-37FB96577EF8Q36967950-8D7CEE0B-864C-4CEF-94A9-9081980AFEB7Q37036440-404059CD-A63D-46F6-940C-CBB4D41FBE68Q37130757-5600B6A4-B426-4794-A17F-79294B6D18B3Q37984498-8CA965DD-9D67-4332-9454-BB63431B9EBDQ38067443-AD12CDC5-ECAD-4E6B-AF61-9D6BCA214D30Q38206217-9197A2E0-F1E3-4333-86EE-11B543B187EFQ38879638-07933604-7785-40E1-B9C6-0FCC8B9052DBQ38948393-8C0FC46F-267A-4935-9DC4-844A1E067BB3Q38989032-363D644C-DCD0-4E08-923B-49FC2937716F
P2860
Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Female genital tract secretion ...... xually transmitted infections.
@ast
Female genital tract secretion ...... xually transmitted infections.
@en
Female genital tract secretion ...... xually transmitted infections.
@nl
type
label
Female genital tract secretion ...... xually transmitted infections.
@ast
Female genital tract secretion ...... xually transmitted infections.
@en
Female genital tract secretion ...... xually transmitted infections.
@nl
prefLabel
Female genital tract secretion ...... xually transmitted infections.
@ast
Female genital tract secretion ...... xually transmitted infections.
@en
Female genital tract secretion ...... xually transmitted infections.
@nl
P2093
P2860
P921
P1476
Female genital tract secretion ...... xually transmitted infections.
@en
P2093
Betsy C Herold
Marla J Keller
Rebecca P Madan
P2860
P304
P356
10.1111/J.1600-0897.2010.00932.X
P577
2010-12-12T00:00:00Z